Neuroscience Institute Receives Primary Stroke Center Designation
The Neuroscience Institute at UC and University Hospital (UH) has earned Primary Stroke Center certification from the national Joint Commission on Accreditation of Healthcare Organizations (JCAHO).
The UC/UH Primary Stroke Center is one of only about 140 in the country to receive JCAHO certification, which is based on the Brain Attack Coalitions recommendations for primary stroke centers and the American Stroke Association's statements guidelines for stroke care.
Although the Neuroscience Institute is receiving the Primary Stroke Center designation, said Joseph Broderick, MD, chairman of UCs neurology department, every member of the Greater Cincinnati/Northern Kentucky Stroke Team, every health-care professional who cares for stroke patients at University Hospital and every cerebrovascular researcher at UC shares in this award.
Each year about 700,000 Americans experience a new or recurrent strokeor one about every 45 secondsmaking it the nation's third leading cause of death and a major cause of serious, long-term disability. Someone dies of a stroke about every three minutes.
Fast treatment is key to stroke survival. If evaluated and treated within three hours with the clot-dissolving drug tPA, the stroke patient stands a good chance of full recovery.
Established in 1999, the Neuroscience Institute is run jointly by nine academic departments at UC College of Medicine, University Hospital and independent physician practice groups.
Greater Cincinnati/Northern Kentucky Stroke Team, based at UC College of Medicine, was founded in the 1980s to help local hospitals quickly diagnose and treat stroke and to pursue research into stroke prevention and treatment.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.